Assessment [hlca]
Liquid [sbst]
Captopril [aapp, phsu]
Formulation [resa]
Children [aggp]
Objective [inpr]
Liquid [sbst]
Captopril [aapp, phsu]
Formulation [resa]
To [qlco]
TREAT [ftcn]
Children [aggp]
Heart disease [dsyn]
This [euka]
Study [mnob]
Assessed [acty]
Bioequivalence [qlco]
Two [qnco]
Liquid [sbst]
Preparation [ftcn]
Licensed [rnlw]
Tablet [bodm]
Form [qlco]
Design [acty]
OPEN LABEL TREATMENT [resa]
Single [popg]
Dose [qnco]
Three [qnco]
Three [qnco]
Trial, Crossover [resa]
setting [ftcn]
Out-patient [podg]
Patients [podg]
Healthy Volunteers [popg]
Adult [aggp]
N NOS [aapp, imft]
interventions [hlca]
Subject [grup]
Assigned [ftcn]
One [qnco]
Six [qnco]
Dose [qnco]
Sequences [nusq]
Dose [qnco]
mg% [qnco]
Captopril [aapp, phsu]
Three [qnco]
Dose [qnco]
Visits [bhvr]
Separated [fndg]
Washout [tmco]
days [tmco]
blood samples [bdsu]
PHARMACOKINETIC [resa]
Analysis [lbpr]
Taken [cnce]
Regular [qlco]
intervals [tmco]
H+ [elii]
Post-dose [tmco]
Main [qlco]
Outcome [ftcn]
Measure [qnco]
Bioequivalence [qlco]
Formulation [resa]
conclude [bodm, orch]
If [qlco]
Estimated [qnco]
Ratio [qnco]
Means [cnce]
Cmax [qnco]
Maximum Concentration [qnco]
Plasma [bdsu]
Area Under Curve [qnco]
Extent [spco]
Absorption [npop]
Range [qnco]
Result [ftcn]
Liquid [sbst]
Formulation [resa]
Failed [ftcn]
Bioequivalence [qlco]
Assessment [hlca]
Cmax [qnco]
Area Under Curve [qnco]
Mean [qnco]
Ratio [qnco]
Liquid [sbst]
Licensed [rnlw]
Tablet [bodm]
Cmax [qnco]
Area Under Curve [qnco]
Fall [fndg]
Outside [spco]
limits [ftcn]
Subject [grup]
Variability [cnce]
Cmax [qnco]
Area Under Curve [qnco]
Conclusions [idcn]
Captopril [aapp, phsu]
Formulation [resa]
Not [ftcn]
Bioequivalence [qlco]
Licensed [rnlw]
Tablet [bodm]
Form [qlco]
SO [geoa]
Assumed [inpr]
To [qlco]
therapeutic use [topp]
Formulation [resa]
Substitution [idcn]
Care [acty]
Increased [qnco]
Monitoring [hlca]
Subject [grup]
Variability [cnce]
Performance [inbe]
Clinical [qlco]
Titrate [hlca]
Optimum [qlco]
Therapeutic [topp]
Dose [qnco]
